Companies of the Staphyt Group2026-05-06T21:40:45+02:00

Companies of the Staphyt Group


Strategic growth with a global presence

Staphyt is a global company that operates in an integrated manner across research, field testing, and regulatory affairs. Throughout its history, the company has expanded its international presence through strategic acquisitions, incorporating complementary competencies and strengthening its ability to serve projects on a global scale.

Today, with a presence in 17 countries and more than 50 testing facilities, Staphyt combines local expertise with a consolidated global structure, offering consistent solutions aligned with the demands of key markets.

Discover our most recent acquisitions

The companies acquired by Staphyt reflect its growth strategy focused on technical excellence and global expansion.

Héliantis

A French company with over 30 years of experience in variety experimentation and seed production, structured around three stations and a wide network of agricultural tests. Its activities range from cultivar evaluation and selection to seed production and multiplication, with dozens of experimental sites and partnerships with producers. With the acquisition of its subsidiaries, Staphyt incorporated this expertise, significantly strengthening its capabilities in seed testing, production, and agricultural experimentation in Europe.

SciReg, Inc.

A US-based regulatory consulting firm specializing in supporting the registration and compliance of products such as pesticides, biopesticides, fertilizers, pharmaceuticals, and chemicals. The company offers strategic services including regulatory development, technical analysis, dossier preparation, support with agencies such as the EPA and FDA, as well as labeling and safety guidance, helping clients navigate complex regulatory environments efficiently on a global scale.

A global company with structured growth.

A company that combines international presence, scientific depth, and a consolidated growth strategy, positioning itself as a strategic partner for companies operating in complex and highly demanding regulatory environments.

Staphyt does not operate as an isolated group of companies. Each acquisition is fully integrated into its global operation, ensuring methodological consistency, technical quality, and regulatory alignment.

This integration allows:

  • Conducting multi-country studies

  • Standardization of protocols

  • Greater data reliability

  • Reducing regulatory risks

Go to Top